Medical-Surgical Intensive Care Unit, Dupuytren Teaching Hospital, Limoges Cedex, France.
Ann Emerg Med. 2012 Jun;59(6):540-4. doi: 10.1016/j.annemergmed.2011.07.029. Epub 2011 Aug 20.
We describe 3 patients admitted to the medical-surgical ICU in a university hospital with life-threatening cardiogenic shock after the ingestion of high doses of calcium channel blockers (8.4 g sustained-release diltiazem, 4.2 g sustained-release diltiazem, and 14.4 g slow-release verapamil). Cardiovascular failure and cardiac conduction disturbances were unresponsive to the usual therapy (eg, intravenous injection of high doses of calcium, glucagon, hyperinsulinemia-euglycemia therapy, fluid resuscitation) and to increasing doses of simultaneous infusions of adrenergic agonists. Albumin dialysis with Molecular Adsorbents Recirculating System (MARS) therapy was performed because of its unique ability to selectively remove from circulation protein-bound toxins (and potentially drugs) that are not cleared by conventional hemodialysis. A single procedure was successfully performed in each patient, which was followed by rapid weaning of adrenergic agonist agents and full recovery of the life-threatening cardiovascular failure. At 2-year follow-up, patients were asymptomatic. Albumin dialysis with MARS therapy may be effective when used as a rescue procedure in patients presenting with sustained, life-threatening cardiogenic shock as a result of massive calcium channel blocker poisoning.
我们描述了 3 名因摄入大剂量钙通道阻滞剂(8.4 g 缓释地尔硫卓、4.2 g 缓释地尔硫卓和 14.4 g 缓释维拉帕米)后出现危及生命的心源性休克而被收入大学医院内科-外科重症监护病房的患者。心血管衰竭和心脏传导障碍对常规治疗(例如静脉注射大剂量钙、胰高血糖素、高胰岛素血症-正常血糖治疗、液体复苏)和肾上腺素能激动剂的剂量增加均无反应。由于其独特的能力,可以选择性地从循环中清除未被常规血液透析清除的蛋白结合毒素(和潜在药物),因此进行了白蛋白透析与分子吸附再循环系统(MARS)治疗。每位患者均成功进行了单次治疗,随后迅速停用肾上腺素能激动剂,并完全恢复危及生命的心衰。在 2 年的随访中,患者无症状。白蛋白透析与 MARS 治疗在因大剂量钙通道阻滞剂中毒导致持续危及生命的心源性休克的患者中作为抢救治疗可能有效。